Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein

Journal of Neuroimmunology

Volumn 79, Issue 2, 1997, Pages 119-128

  Genain, Claude P ^a   Gritz, Linda ^c   Joshi, Narendra ^a   Panicali, Dennis ^c   Davis, Richard L ^b   Whitaker, John N ^e   Letvin, Norman L ^d   Hauser, Stephen L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Therion Biologics Corporation   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Demyelination; Multiple sclerosis; Myelin antigens; Post vaccinial encephalitis; T cell reactivity; Tolerance

Indexed keywords

MYELIN BASIC PROTEIN; VACCINIA VACCINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DEMYELINATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MARMOSET; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRAL GENETICS;

ANIMALS; ANTIBODIES; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, VIRAL; CALLITHRIX; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MYELIN BASIC PROTEINS; VACCINATION; VACCINES, SYNTHETIC; VACCINIA; VACCINIA VIRUS; VIRAL VACCINES;

EID: 0030781981     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00109-4     Document Type: Article

References (39)

1. Allegretta M., Nicklas J.A., Sriram S., Albertini R.J. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science. 247:1990;718-721.
2. Barnett L.A., Whitton J.L., Wada Y., Fujinami R.S. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 44:1993;15-25.
3. Barnett L.A., Whitton J.L., Wang L.-Y., Fujinami R.S. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J. Neuroimmunol. 64:1996;163-173.
4. Bennink J.R., Yewdell J.W. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Curr. Topics Microbiol. Immunol. 163:1990;153-184.
5. Chen Y., Kuchroo V.K., Inobe J.-I., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
6. Chunduru S.K., Sutherland R.M., Stewart G.A., Doms R.W., Paterson Y. Exploitation of the Vb8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector. J. Immunol. 156:1996;4940-4945.
7. Cooney E.L., Collier A.C., Greenberg P.D., Coombs R.W., Zarling J., Arditti D.E., Hoffman M.C., Hu S.-L., Corey L. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet. 337:1991;567-572.
8. Critchfield J.M., Racke M.K., Zuniga-Pflucker J.C., Cannella B., Raine C.S., Goverman J., Lenardo M.J. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science. 263:1994;1139-1143.
9. Deibler G.E., Martenson R.E., Kies M.W. Large scale preparation of myelin basic protein in central nervous tissue of several mammalian species. Prep. Biochem. 2:1972;139-165.
10. Genain C.P., Hauser S.L. Allergic encephalomyelitis in common marmosets: Pathogenesis of a multiple sclerosis-like lesion. Methods: A companion to Methods Enzymol. 10:1996;420-434.
11. Genain C.P., Lee-Parritz D., Nguyen M.H., Massacesi L., Joshi N., Ferrante R., Hoffman K., Moseley M., Letvin N.L., Hauser S.L. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J. Clin. Invest. 94:1994;1339-1345.
12. Genain C.P., Nguyen M.H., Letvin N.L., Pearl R., Davis R.L., Adelman M., Lees M.B., Linington C., Hauser S.L. Antibody facilitation of multiple sclerosis-like lesions in a non human primate. J. Clin. Invest. 96:1995;2966-2974.
13. Genain C.P., Roberts T., Davis R.L., Nguyen M.H., Uccelli A., Faulds D., Li Y., Hedgpeth J., Hauser S.L. Prevention of autoimmune demyelination by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA. 92:1995;3601-3605.
14. Gillard S., Spehner D., Drillien R., Kirn A. Localization and sequence of a vaccinia virus gene required for multiplication in human cells. Proc. Natl. Acad. Sci. USA. 83:1986;5573-5577.
15. Gritz L., Destree A., Cormier N., Day E., Stallard V., Caiazzo T., Mazzara G., Panicali D. Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: Application to human deficiency virus type 1 env. J. Virol. 64:1990;5948-5957.
16. Gutierrez-Ramos J.C., Andreu J.L., Revilla Y., Vinuela E., Martinez-A C. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature. 346:1990;271-274.
17. Hogervorst E.J.M., Schouls L., Wagenaar J.P.A., Boog C.J.P., Spaan W.J.M., van Embden J.D.A., van Eden W. Modulation of experimental autoimmunity: Treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus. Infect. Immun. 59:1991;2029-2035.
18. Kamholz J., Spielman R., Gogolin K., Modi W., O'Brien S., Lazzarini R. The human myelin basic protein gene: Chromosomal localization and RFLP analysis. Am. J. Hum. Genet. 40:1987;365-373.
19. Khoury S., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental allergic encephalomyelitis are associated with down regulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1992;1355-1363.
20. Koh D.-R., Fung-Leung W.-P., Ho A., Gray D., Acha-Orbea H., Mak T.-W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice. Science. 256:1992;1210-1213.
21. Kroemer G., de Cid R., Moreno de Alboran I., Gonzalo J.-A., Iglesias A., Matinez-A. C., Gutierrez-Ramos J.C. Immunological self-tolerance: An analysis employing cytokines or cytokine receptors encoded by transgenes or a recombinant vaccinia virus. Immunol. Rev. 122:1991;173-204.
22. Lane J.M., Ruben F.L., Neff J.M., Millar J.D. Complications of smallpox vaccination, 1968. National surveillance in the United States. New Engl. J. Med. 281:1969;1201.
23. Lees, M.B., Sakur, J.D., 1979. Preparation of proteolipids. In: Marks, N., Rodnight, R. (Eds.), Research Methods in Neurochemistry. Plenum Press, New York, pp. 354-370.
24. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34-38.
25. Lopez-Guerrero, J.A., Ortiz, M.A., Paez, E., Bernabeu, C., Lopez-Bote, J.P., 1994. Therapeutic effect of recombinant vaccinia virus expressing the 60 kd heat-shock protein on adjuvant arthritis. Arthritis Rheum., 1462-1467.
26. Massacesi L., Genain C.P., Lee-Parritz D., Letvin N.L., Canfield D., Hauser S.L. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis. Ann. Neurol. 37:1995;519-530.
27. Miller S.D., Karpus W.J. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today. 15:1994;356-361.
28. Miller A., Lider O., Weiner H.L. Antigen driven bystander suppression after oral administration of antigen. J. Exp. Med. 174:1991;791-798.
29. Moss B. Vaccinia virus: A tool for research and vaccine development. Science. 252:1991;1662-1667.
30. Oksenberg J.R., Panzara M.A., Begovich A.B., Mitchell D., Erlich H.A., Murray R.S., Shimonkevitz R., Sherrity M., Rothbard J., Bernard C.C.A., Steinman L. Selection for T cell receptor Vb-Db-Jb gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:1993;68-70.
31. Olsson T., Wang W.Z., Hojeberg B., Kostulas V., Jiang Y.-P., Anderson G., Ekre H.P., Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon. J. Clin. Invest. 86:1990;981-985.
32. Paterson P.Y. Molecular and cellular determinants of neuroimmunologic inflammatory disease. Fed. Proc. 41:1982;2569-2576.
33. Pettinelli C.B., McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt 1+2- T lymphocytes. J. Immunol. 127:1981;1420-1423.
34. Shen L., Chen Z.W., Miller M.D., Stallard V., Mazzara G.P., Panicali D.L., Letvin N.L. Induction of simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes following vaccination with a recombinant virus vaccine. Science. 252:1991;440-443.
35. Smith K., Stallard V., Roos J., Hart C., Cormier N., Cohen L., Roberts B., Payne L. Host range selection of vaccinia recombinants containing insertions of foreign genes into non coding sequences. Vaccine. 11:1993;43-53.
36. Sun D., Qin Y., Chluba J., Epplen J.T., Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature. 332:1988;843-845.
37. Whitaker J.N., Chou C.-H.J., Chou F.C.-H., Kibler R.F. Antigenic regions for the humoral response to myelin basic protein. Mol. Immunol. 16:1979;495-501.
38. Zamvil S.S., Steinman L. The T-lymphocyte in experimental allergic encephalomyelitis. Ann. Rev. Immunol. 8:1990;579-621.
39. Zhang J.S., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D.A. Increased frequency of interleukin-2 responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1994;973-984.